Low T3 vs low T3T4 euthyroid sick syndrome in septic shock patients: A prospective observational cohort study
- PMID: 39253312
- PMCID: PMC11372517
- DOI: 10.5492/wjccm.v13.i3.96132
Low T3 vs low T3T4 euthyroid sick syndrome in septic shock patients: A prospective observational cohort study
Abstract
Background: Both phases of euthyroid sick syndrome (ESS) are associated with worse prognosis in septic shock patients. Although there are still no indications for supplementation therapy, there is no evidence that both phases (initial and prolonged) are adaptive or that only prolonged is maladaptive and requires supplementation.
Aim: To analyze clinical, hemodynamic and laboratory differences in two groups of septic shock patients with ESS.
Methods: A total of 47 septic shock patients with ESS were divided according to values of their thyroid hormones into low T3 and low T3T4 groups. The analysis included demographic data, mortality scores, intensive care unit stay, mechanical ventilation length and 28-day survival and laboratory with hemodynamics.
Results: The Simplified Acute Physiology Score II score (P = 0.029), dobutamine (P = 0.003) and epinephrine requirement (P = 0.000) and the incidence of renal failure and multiple organ failure (MOF) (P = 0.000) were significantly higher for the low T3T4. Hypoalbuminemia (P = 0.047), neutrophilia (P = 0.038), lymphopenia (P = 0.013) and lactatemia (P = 0.013) were more pronounced on T2 for the low T3T4 group compared to the low T3 group. Diastolic blood pressure at T0 (P = 0.017) and T1 (P = 0.007), as well as mean arterial pressure at T0 (P = 0.037) and T2 (P = 0.033) was higher for the low T3 group.
Conclusion: The low T3T4 population is associated with higher frequency of renal insufficiency and MOF, with worse laboratory and hemodynamic parameters. These findings suggest potentially maladaptive changes in the chronic phase of septic shock.
Keywords: Euthyroid sick syndrome; Intensive care unit; Low T3; Low T3T4; Septic shock.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures



Similar articles
-
Triiodothyronine hormone supplementation therapy in septic shock patients with euthyroid sick syndrome: two pilot, placebo-controlled, randomized trials.Anaesth Crit Care Pain Med. 2024 Apr;43(2):101336. doi: 10.1016/j.accpm.2023.101336. Epub 2023 Dec 5. Anaesth Crit Care Pain Med. 2024. PMID: 38061681
-
Analysis of the Incidence of Euthyroid Sick Syndrome in Comprehensive Intensive Care Units and Related Risk Factors.Front Endocrinol (Lausanne). 2021 Jun 9;12:656641. doi: 10.3389/fendo.2021.656641. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34177801 Free PMC article.
-
Prognostic significance of thyroid hormone T3 in patients with septic shock: a retrospective cohort study.PeerJ. 2023 May 16;11:e15335. doi: 10.7717/peerj.15335. eCollection 2023. PeerJ. 2023. PMID: 37214092 Free PMC article.
-
[Value of pulse indicator continuous cardiac output monitoring of cardiac function in septic shock patients: a prospective study].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Jan;27(1):22-7. doi: 10.3760/cma.j.issn.2095-4352.2015.01.006. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015. PMID: 25591432 Chinese.
-
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. Crit Care Med. 2013. PMID: 23353941
References
-
- Widmer A, Schuetz P. Endocrine dysfunction during sepsis—are changes in hormone levels a physiological adaptation or a therapeutic target? J Lab Precis Med. 2018;3:61–61.
LinkOut - more resources
Full Text Sources